Cooley
Todd Gluth
- Deals
- 5
- Latest
- Jun 2026
- Most deals in
- Biotech
Firm
- Cooley Law firm · 2026 · 5 deals
Often works with
- Megan Browdie 4 deals together
- Lindsey O'Crump 2 deals together
- Ross Eberly 2 deals together
- Tony Guan 2 deals together
- Allison Nostdahl 2 deals together
- Rama Padmanabhan 2 deals together
- Jenny Ge 2 deals together
- Sharon Connaughton 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jun 2026 | First Street | – | MSCI | Acquisition | Legal adviser to First Street (target) | Announced | 120.0 | Data & Analytics+1 | MSCI acquisition of First Street |
| May 2026 | Vaccine Company | – | Lilly | Acquisition | Legal adviser to Vaccine Company (target) | Announced | 1,550.0 | Biotech+1 | Lilly acquisition of Vaccine Company |
| May 2026 | Candid Therapeutics | – | UCB | Acquisition | Legal adviser to Candid Therapeutics (target) | Announced | 2,200.0 | Biotech+1 | UCB acquisition of Candid Therapeutics |
| Mar 2026 | PFF enterprise (B2B) business | Pro Football Focus | Teamworks | Asset sale | Legal adviser to Pro Football Focus (seller) | Announced | – | Data & Analytics | Teamworks acquisition of PFF enterprise (B2B) business |
| Feb 2026 | 35Pharma | – | GSK | Acquisition | Legal adviser to 35Pharma (target) | Announced | 950.0 | Biotech+1 | GSK acquisition of 35Pharma |
Deals where Todd Gluth is named on the firm's deal team, by the firm or the press.